Medication stock photo

HHS Releases New Buprenorphine Practice Guidelines, Expanding Access to Treatment for Opioid Use Disorder

May 11, 2021 | Julia Zigman

In an effort to get evidenced-based treatment to more Americans with opioid use disorder, the Department of Health and Human Services (HHS) is releasing new buprenorphine practice guidelines that among other things, remove a longtime requirement tied to training, which some practitioners have cited as a barrier to treating more people.

Signed by HHS Secretary Xavier Becerra, the Practice Guidelines for the Administration of Buprenorphine for Treating Opioid Use Disorder exempt eligible physicians, physician assistants, nurse practitioners, clinical nurse specialists, certified registered nurse anesthetists and certified nurse midwives from federal certification requirements related to training, counseling and other ancillary services that are part of the process for obtaining a waiver to treat up to 30 patients with buprenorphine.

More than 90,000 drug overdose deaths are predicted to have occurred in the United States in the 12 months ending in September 2020, the highest number of overdose deaths ever recorded in a 12-month period, according to provisional data from the Centers for Disease Control and Prevention, and overdose deaths have continued to accelerate during the COVID-19 pandemic.

The alarming increase in overdose deaths underscores the need for more accessible treatment services, and studies have shown that medication-based treatment promotes long-term recovery from opioid use disorder.

Continue reading at HHS.gov.


NACCHO logo small version02 square N pms321 Invert

About Julia Zigman

Pronouns: she/her

Julia Zigman is a Program Analyst on the NACCHO HIV, STI, & Viral Hepatitis team. Julia focuses primarily on NACCHO’s Ending the HIV Epidemic portfolio and is a lead staff member for the HIV, STI, and Viral Hepatitis Workgroup. Learn more about these programs here.

More posts by Julia Zigman

Related Posts

Syringe pile
  • HIV, STI, & Viral Hepatitis
  • Opioid Overdose Epidemic

White House Centers Harm Reduction and Equity in Year 1...

On April 1, the White House Office of National Drug Control Policy (ONDCP)...

Apr 07, 2021 | Kat Kelley

White House Centers Harm Reduction and Equity in Year 1...

Syringe pile
  • Funding Opportunity
  • HIV, STI, & Viral Hepatitis
  • Opioid Overdose Epidemic

Funding Opportunity: Building Capacity for Harm...

NACCHO is pleased to announce a funding opportunity to promote monitoring and...

Apr 12, 2021 | Kat Kelley

Funding Opportunity: Building Capacity for Harm...

Webinar
  • Webinar
  • HIV, STI, & Viral Hepatitis
  • Opioid Overdose Epidemic

Using M&E to Better Serve Your Community: A Four-Part...

This four-part webinar series explores how syringe services programs (SSPs) can...

Apr 28, 2021 | Kat Kelley

Using M&E to Better Serve Your Community: A Four-Part...

Opioid
  • HIV, STI, & Viral Hepatitis

Improving the Health of People Who Use Drugs and People...

The O’Neill Institute at Georgetown Law released a Big Ideas brief and...

Apr 01, 2021 | Julia Zigman

Improving the Health of People Who Use Drugs and People...

Back to Top